Clinical Trial: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter II

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter

Brief Summary:

The purpose of this clinical study is to assess the safety and performance of the Vision-MR Ablation Catheter, the primary safety endpoint will measure the rate of serious adverse events related to the device or procedure; the primary performance endpoint will measure the acute success rate defined as the demonstration of bidirectional cavo-tricuspid isthmus block after radiofrequency application in the cavo-tricuspid isthmus; the secondary performance endpoint will measure the chronic success rate defined as the freedom of recurrence of type 1 atrial flutter at three months post-ablation procedure. The study will be a single center study conducted at the Leipzig University Hospital Heart Center in Germany. The study population will consist of adult patients requiring ablation for type I atrial flutter.

This is the follow-up study to NCT02699034.